PDCD1 and Hepatitis: 3 out of 11 cases were diagnosed with HBV-associated hepatitis, and 2 of them discontinued PD-1 inhibitors due to hepatitis flare and HBV-related acute-on-chronic liver failure (ACLF), respectively.